KRM Ayurveda IPO: Price, GMP, Dates, Financials & Analysis
KRM Ayurveda IPO details including GMP or grey market premium, price, date, listing date, allotment date & status with company financials.
Shivam.Finowings 
The KRM Ayurveda IPO is gaining attention in the SME segment as interest in Ayurvedic healthcare and telemedicine continues to grow in India. KRM Ayurveda Limited operates a network of Ayurvedic hospitals and clinics and offers wellness services both offline and through digital consultation platforms.
KRM Ayurveda IPO Overview
KRM Ayurveda IPO GMP is a book-built SME IPO with a total issue size of ₹77.49 crore, consisting entirely of a fresh issue of 57.40 lakh shares. The IPO opens for subscription on January 19, 2026, and closes on January 21, 2026. The shares are expected to list on NSE SME on January 27, 2026.
Price Band: ₹128 – ₹135 per share
Face Value: ₹10 per share
Lot Size: 1,000 shares
Issue Type: Book Build Issue
Company Profile
KRM Ayurveda Limited operates 6 hospitals and 5 clinics across India, supported by telemedicine services for domestic and international patients. Its offerings include Panchakarma therapies, inpatient and outpatient care, wellness packages, herbal medicines, dietary counselling, yoga, and lifestyle management.
The company follows GMP-certified manufacturing for its Ayurvedic formulations and focuses on standardized healthcare delivery.
Financial Performance
KRM Ayurveda has shown steady financial growth:
FY25 Revenue: ₹76.95 crore
FY25 PAT: ₹12.10 crore
EBITDA Margin: ~25%
ROE: 67.86%
The improving profitability and expanding net worth indicate operational scalability.
Objectives of the Issue
The proceeds from the KRM Ayurveda IPO will be used for:
Expansion of telemedicine infrastructure
Investment in CRM and IT systems
Hiring medical and operational staff
Repayment of existing borrowings
Working capital and general corporate purposes
Valuation & Peer Comparison
Based on FY25 earnings, the IPO is valued at a P/E of ~16.7x, which appears reasonable compared to listed peers in the Ayurvedic healthcare space.
KRM Ayurveda IPO GMP Today
As of 16 January 2026, the KRM Ayurveda IPO GMP stands at ₹15. At the upper price band of ₹135, this indicates a potential listing price of around ₹150, suggesting an estimated upside of ~11%, though GMP is unofficial and market-driven.
Strengths & Risks
Strengths:
Integrated healthcare + telemedicine model
Qualified Ayurvedic doctors and therapists
Strong margins and repeat customer base
Risks:
High operational complexity across locations
Dependence on herbal raw materials
Limited brand presence in newer regions
Conclusion
The KRM Ayurveda IPO GMP presents a growth-oriented SME opportunity backed by expanding healthcare demand, improving financials, and digital scalability. While valuation and GMP trends appear encouraging, investors should assess debt levels and execution risks before applying.
Disclaimer: This content is for educational purposes only and not investment advice. Please consult a SEBI-registered advisor before investing.
